Michel Attal

1990–2022 年に発表

141
論文数
41,361
被引用数
103
h 指数
141
i10 指数

被引用数

Michel Attal の年別被引用数1948 年: 被引用 1 件1988 年: 被引用 4 件1989 年: 被引用 1 件1990 年: 被引用 1 件1991 年: 被引用 5 件1992 年: 被引用 7 件1993 年: 被引用 14 件1994 年: 被引用 14 件1995 年: 被引用 11 件1996 年: 被引用 24 件1997 年: 被引用 22 件1998 年: 被引用 37 件1999 年: 被引用 37 件2000 年: 被引用 75 件2001 年: 被引用 68 件2002 年: 被引用 90 件2003 年: 被引用 106 件2004 年: 被引用 87 件2005 年: 被引用 90 件2006 年: 被引用 102 件2007 年: 被引用 150 件2008 年: 被引用 180 件2009 年: 被引用 271 件2010 年: 被引用 272 件2011 年: 被引用 348 件2012 年: 被引用 269 件2013 年: 被引用 331 件2014 年: 被引用 276 件2015 年: 被引用 285 件2016 年: 被引用 283 件2017 年: 被引用 348 件2018 年: 被引用 258 件2019 年: 被引用 1,176 件2020 年: 被引用 1,538 件2021 年: 被引用 1,373 件2022 年: 被引用 932 件2023 年: 被引用 572 件2024 年: 被引用 879 件2025 年: 被引用 291 件2026 年: 被引用 4 件1949〜1987 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,727 件、この内訳の 24.7%フランス: 引用元論文 788 件、この内訳の 7.1%イタリア: 引用元論文 729 件、この内訳の 6.6%ドイツ: 引用元論文 698 件、この内訳の 6.3%イギリス: 引用元論文 686 件、この内訳の 6.2%スペイン: 引用元論文 592 件、この内訳の 5.4%中国: 引用元論文 483 件、この内訳の 4.4%カナダ: 引用元論文 395 件、この内訳の 3.6%オランダ: 引用元論文 391 件、この内訳の 3.5%オーストラリア: 引用元論文 294 件、この内訳の 2.7%ギリシャ: 引用元論文 292 件、この内訳の 2.6%ベルギー: 引用元論文 239 件、この内訳の 2.2%
0%24.7%その他 24.7%

分野

  • Medicine85.1%
  • Biochemistry, Genetics and Molecular Biology10.6%
  • Immunology and Microbiology2.5%
  • Computer Science0.3%
  • Mathematics0.3%
  • Chemistry0.2%
  • その他1%

トピック

  • Multiple Myeloma Research and Treatments21.2%
  • Protein Degradation and Inhibitors8.8%
  • Peptidase Inhibition and Analysis4.7%
  • Hematopoietic Stem Cell Transplantation4.3%
  • Acute Myeloid Leukemia Research3.5%
  • Cancer Treatment and Pharmacology3.4%
  • その他54.1%

共著者

全論文

検索で開く
  1. Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Philippe Moreau - Journal of Clinical Oncology 2015 被引用: 2,178

  2. Bortezomib, thalidomide, and dexamethasone with or without daratumumab before and after autologous stem-cell transplantation for newly diagnosed multiple myeloma (CASSIOPEIA): a randomised, open-label, phase 3 study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Soraya Wuillème, Sonja Zweegman, Brigitte Kolb, Cyrille Touzeau, Murielle Roussel, Mourad Tiab, Jean‐Pierre Marolleau, Nathalie Meuleman, Marie‐Christiane Vekemans, Matthijs Westerman, Saskia K. Klein, Mark‐David Levin, Jean Paul Fermand, Martine Escoffre‐Barbe, Jean‐Richard Eveillard, Réda Garidi, Tahamtan Ahmadi, Sen Hong Zhuang, Christopher Chiu, Lixia Pei, Carla de Boer, Elena Smith, William Deraedt, Tobias Kampfenkel, Jordan M. Schecter, Jessica Vermeulen, Hervé Avet‐Loiseau, Pieter Sonneveld - The Lancet 2019 被引用: 953

  3. Lenalidomide, Bortezomib, and Dexamethasone with Transplantation for Myeloma

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2017 被引用: 1,234

  4. Daratumumab plus Lenalidomide and Dexamethasone for Untreated Myeloma

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2019 被引用: 987

  5. Triplet Therapy, Transplantation, and Maintenance until Progression in Myeloma

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Adam D. Cohen, Thomas H. Openshaw, Marcelo C. Pasquini, Sergio Giralt, Jonathan L. Kaufman, Andrew J. Yee, Emma C. Scott, Pallawi Torka, Amy Foley, Mariateresa Fulciniti, Kyle Hebert, Mehmet Samur, Kelly Masone, Michelle E. Maglio, Andrea A. Zeytoonjian, Omar Nadeem, Robert Schlossman, Jacob P. Laubach, Claudia E. Paba‐Prada, Irene M. Ghobrial, Aurore Perrot, Philippe Moreau, Hervé Avet‐Loiseau, Michel Attal, Kenneth C. Anderson, Nikhil C. Munshi - New England Journal of Medicine 2022 被引用: 463

  6. Isatuximab plus pomalidomide and low-dose dexamethasone versus pomalidomide and low-dose dexamethasone in patients with relapsed and refractory multiple myeloma (ICARIA-MM): a randomised, multicentre, open-label, phase 3 study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jeffrey Shang-Yi Huang, Jiří Minařík, Michèle Cavo, H. Miles Prince, Sandrine Macé, Kathryn P. Corzo, Frank Campana, Solenn Le-Guennec, Franck Dubin, Kenneth C. Anderson, Simon J. Harrison, Wojciech Janowski, Ian Kerridge, Andrew Spencer, Michel Delforge, Karel Fostier, Philip Vlummens, Ka Lung Wu, Richard LeBlanc, Michel Pavic, Michaël Sébag, Roman Hájek, Vladimír Maisnar, Luděk Pour, Henrik Gregersen, Lotfi Benbouker, Denis Caillot, Martine Escoffre‐Barbe, Thierry Façon, Laurent Frenzel, Cyrille Hulin, Lionel Karlin, Brigitte Kolb, Brigitte Pegourié, Aurore Perrot, Mourad Tiab, Laure Vincent, Dietger Niederwieser, Αchilles Anagnostopoulos, Sosana Delimpasi, Marie‐Christine Kyrtsonis, Anargyros Symeonidis, Árpád Illés, Gábor Mikala, Zsolt Nagy, Sara Bringen, Paolo Corradini, Fabio Ciceri, Roberto M. Lemoli, Anna Marina Liberati, Chiara Nozzoli, Renato Zambello, Shinsuke Iida, Takashi Ikeda, Satoshi Iyama, Morio Matsumoto, Chihiro Shimazaki, Kazutaka Sunami, Kenshi Suzuki, Michihiro Uchiyama, Youngil Koh, Kihyun Kım, Jae Hoon Lee, Chang‐Ki Min, Hillary Blacklock, Hugh J. B. Goodman, Annette Neylon, David Simpson, Sebastian Grosicki, Artur Jurczyszyn ほか 30 名 - The Lancet 2019 被引用: 636

  7. International uniform response criteria for multiple myeloma

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , on behalf of the International Myeloma Working Group - Leukemia 2006 被引用: 2,639

  8. Minimal residual disease negativity using deep sequencing is a major prognostic factor in multiple myeloma

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Tom Willis, Malek Faham, Kenneth C. Anderson, Jean‐Luc Harousseau, Xavier Leleu, Thierry Façon, Philippe Moreau, Michel Attal, Hervé Avet‐Loiseau, Nikhil C. Munshi - Blood 2018 被引用: 420

  9. Treatment of multiple myeloma with high-risk cytogenetics: a consensus of the International Myeloma Working Group

    著者: , , , , , , , , , , , , , , , , , , , , - Blood 2016 被引用: 929

  10. Heterogeneity of genomic evolution and mutational profiles in multiple myeloma

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Thierry Façon, P. Andrew Futreal, Kenneth C. Anderson, Peter J. Campbell, Nikhil C. Munshi - Nature Communications 2014 被引用: 906

  11. Pembrolizumab plus pomalidomide and dexamethasone for patients with relapsed or refractory multiple myeloma (KEYNOTE-183): a randomised, open-label, phase 3 trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Mohamed Elemary, Nizar J. Bahlis, Thierry Façon, Lionel Karlin, Vincent Ribrag, Michel Attal, Hartmut Goldschmidt, Monika Engelhardt, Katja Weisel, Andréas Mackensen, Arnon Nagler, Dina Ben Yehuda, Irit Avivi, Noam Benyamini, Hila Magen‐Nativ, Antonio Palumbo, Michèle Cavo, Kensei Tobinai, Shinsuke Iida, Takaai Chou, Kenshi Suzuki, Hiroshi Kosugi, Masafumi Taniwaki, Kazutaka Sunami, Morio Matsumoto, Kiyoshi Ando, Peter Ganly, Hilary Blacklock, David Simpson, Anupkumar George, Fredrik Schjesvold, Bjørn Tore Gjertsen, Juan José Lahuerta, Joan Bladé, Albert Oriol Rocafiguera, María‐Victoria Mateos, Paula Rodríguez‐Otero, Sarah M. Larson, Djordje Atanackovic, Srinivas Devarakonda, Jacob D. Bitran, Jeffrey A. Zonder, Neil Morganstein, Mohammad Hay, Asher Chanan‐Khan, Gene Saylors, Ebenezer A. Kio, Ira Oliff, Dean Kirkel, Mikhail Shtivelband, Carrie Yuen, Andrew J. Yee, Jatin J. Shah, Myo Htut, Shahzad Raza, Saurabh Chhabra, Patrick J. Stiff, Parameswaran Hari, Bruce Bank, Ehsan Malek, Cristina Gasparetto, Ycaoub Faroun, Daniel W. Sherbenou, William Kreisle, Seema Singhal, Jacalyn Rosenblatt, Saad Z. Usmani, Wes Lee, Hana Safah, Jose Lutzky ほか 21 名 - The Lancet Haematology 2019 被引用: 253

  12. Lenalidomide Maintenance After Autologous Stem-Cell Transplantation in Newly Diagnosed Multiple Myeloma: A Meta-Analysis

    著者: , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2017 被引用: 679

  13. Development and Validation of a Cytogenetic Prognostic Index Predicting Survival in Multiple Myeloma

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2019 被引用: 179

  14. Anti–B-Cell Maturation Antigen BiTE Molecule AMG 420 Induces Responses in Multiple Myeloma

    著者: , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2020 被引用: 299

  15. Pembrolizumab plus lenalidomide and dexamethasone for patients with treatment-naive multiple myeloma (KEYNOTE-185): a randomised, open-label, phase 3 trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Lionel Karlin, Thierry Façon, Michel Attal, Katja Weisel, Monika Engelhardt, Andréas Mackensen, John Quinn, Irit Avivi, Amos Cohen, Hila Magen‐Nativ, Noam Benyamini, Michèle Cavo, Alessandra Larocca, Naoki Takezako, Kenshi Suzuki, Hiroshi Kosugi, Morio Matsumoto, Shinsuke Iida, Takayuki Ishikawa, Yukio Kondo, Kazutaka Sunami, Kiyoshi Ando, Takanori Teshima, Takaaki Chou, Hiromi Iwasaki, Hirokazu Miki, Itaru Matsumura, Yasushi Onishi, Koji Izutsu, Masahiro Kizaki, Anupkumar George, Hillary Blacklock, David Simpson, Fredrik Schjesvold, Anders Waage, Olga Samoilova, Evgeniy Nikitin, Tatiana Chagorova, Andrew M. McDonald, Moosa Patel, Albert Oriol, Jesus San Miguel Izquierdo, María‐Victoria Mateos, Matthew Streetly, Peter Forsyth, Graham Jackson, Stephen J. Jenkins, Robert M. Rifkin, Habte Yimer, Robert McCroskey, Danko Martincic, Stefano Tarantolo, Sarah Larson, Yacoub Faroun, Jennifer Vaughn, Rachid Baz, Gene Saylors, Amarendra Neppalli, Anastasios Raptis, Henry C. Fung, Maxwell Janosky, Don A. Stevens, Morton Coleman, Dennis Costa, Scott Cross, Suzanne Fanning, Daniel Farray Berges, Thomas M. Harris, Ira Zackon, Djordje Atanackovic ほか 17 名 - The Lancet Haematology 2019 被引用: 242

  16. A simplified frailty scale predicts outcomes in transplant-ineligible patients with newly diagnosed multiple myeloma treated in the FIRST (MM-020) trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Leukemia 2019 被引用: 230

  17. Lenalidomide and Dexamethasone in Transplant-Ineligible Patients with Myeloma

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Annette Ervin‐Haynes, Hervé Avet‐Loiseau, Cyrille Hulin, Thierry Façon - New England Journal of Medicine 2014 被引用: 786

  18. Lenalidomide Maintenance after Stem-Cell Transplantation for Multiple Myeloma

    著者: , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2012 被引用: 1,153

  19. Prospective Evaluation of Magnetic Resonance Imaging and [18F]Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography at Diagnosis and Before Maintenance Therapy in Symptomatic Patients With Multiple Myeloma Included in the IFM/DFCI 2009 Trial: Results of the IMAJEM Study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2017 被引用: 320

  20. Genetic abnormalities and survival in multiple myeloma: the experience of the Intergroupe Francophone du Myelome

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Stéphane Minvielle, Jean‐Luc Harousseau, Thierry Façon, Claire Mathiot - Blood 2007 被引用: 905

  21. Prevention of thalidomide- and lenalidomide-associated thrombosis in myeloma

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Mario Boccadoro, Brian G.M. Durie, Pieter Sonneveld, M. A. Hussein, on behalf of the International Myeloma Working Group - Leukemia 2007 被引用: 839

  22. International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , R Powles, S. Vincent Rajkumar, Brian G.M. Durie, on behalf of the International Myeloma Working Group - Leukemia 2008 被引用: 809

  23. Early Versus Late Autologous Stem Cell Transplant in Newly Diagnosed Multiple Myeloma: Long-Term Follow-up Analysis of the IFM 2009 Trial

    著者: , , , , , , , , , , , , , , , , , , , , , - Blood 2020 被引用: 124

  24. A Prospective, Randomized Trial of Autologous Bone Marrow Transplantation and Chemotherapy in Multiple Myeloma

    著者: , , , , , , , , , , , - New England Journal of Medicine 1996 被引用: 2,571